Linda C. Battes

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment.

In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: October 07, 2017

Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study.

Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study.

Journal: American heart journal

Published: June 14, 2017

Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.

Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.

Journal: International journal of cardiology

Published: August 05, 2016

Smoking in Relation to Coronary Atherosclerotic Plaque Burden, Volume and Composition on Intravascular Ultrasound.

Smoking in Relation to Coronary Atherosclerotic Plaque Burden, Volume and Composition on Intravascular Ultrasound.

Journal: PloS one

Published: April 15, 2015

Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome.

Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: September 09, 2014

Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients.

Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients.

Journal: Transplantation

Published: August 20, 2014

Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: results from the ATHEROREMO-IVUS study.

Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: results from the ATHEROREMO-IVUS study.

Journal: International journal of cardiology

Published: May 22, 2014

Circulating cytokines in relation to the extent and composition of coronary atherosclerosis: results from the ATHEROREMO-IVUS study.

Circulating cytokines in relation to the extent and composition of coronary atherosclerosis: results from the ATHEROREMO-IVUS study.

Journal: Atherosclerosis

Published: March 14, 2014

Biomarkers of heart failure with normal ejection fraction: a systematic review.

Biomarkers of heart failure with normal ejection fraction: a systematic review.

Journal: European journal of heart failure

Published: July 13, 2013

Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.

Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.

Journal: The American journal of cardiology

Published: December 20, 2012

Microsimulation for clinical decision-making in individual patients with established coronary artery disease: a concept.

Microsimulation for clinical decision-making in individual patients with established coronary artery disease: a concept.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: December 01, 2012

Beta blocker therapy is associated with reduced depressive symptoms 12 months post percutaneous coronary intervention.

Beta blocker therapy is associated with reduced depressive symptoms 12 months post percutaneous coronary intervention.

Journal: Journal of affective disorders

Published: June 30, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026